>Teva Pharmaceutical Industries Ltd., is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. (http://www.tevapharm.com/)

 

>Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. (http://www.barrlabs.com/)

---

>AGREEMENT AND PLAN OF MERGE 

 http://www.sec.gov/Archives/edgar/data/818686/000089914008001470/t4306405b.txt

 

>Press Release:

 

>Conference Calls:

 

 http://www.earnings.com/conferencecallhost.asp?event=1904570&client=cb

 

>Presentations:

 

 

 

>Consideration:

Under the terms of the agreement, each share of Barr common stock will be converted into $39.90 in cash and 0.6272 Teva ADRs

 

>Expected Closed:

 Teva expects the transaction to close in late 2008